Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan So

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 31, 2018
Recommandations de l'Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostateRicardo A Rendon, Ross J Mason, Karim Marzouk, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 1, 2019
Management algorithms for prostate-specific antigen progression in prostate cancer: Biochemical recurrence after definitive therapy and progression to non-metastatic castrate-resistant prostate cancerBrita Danielson, Fred Saad, Alan So, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancerKim N Chi, Martin E Gleave, Ladan Fazli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 26, 2018
The burden of symptomatic skeletal events in castrate-resistant prostate cancer patients with bone metastases at three Canadian uro-oncology centresFred Saad, Neil E Fleshner, Alan So, et al.
World Journal of Urology|March 1, 2018
The impact of time to metastasis on overall survival in patients with prostate cancerSebastian Frees, Shusuke Akamatsu, Samir Bidnur, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2017
CUA guideline on the management of cystic renal lesionsPatrick O Richard, Philippe D Violette, Michael A S Jewett, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 10, 2018
Natural history of prostatic lesions on serial multiparametric magnetic resonance imagingSamrad Ghavimi, Hamidreza Abdi, Jennifer Waterhouse, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 2, 2010
Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapyWassim Kassouf, Ashish M Kamat, Alexander Zlotta, et al.
Cancer Medicine|September 23, 2023
Economic evaluation of prostate cancer risk assessment methods: A cost-effectiveness analysis using population dataTima Mohammadi, Daphne P Guh, Alexander C T Tam, et al.
Oncotarget|June 2, 2018
The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinibSebastian Frees, Betty Zhou, Kyung Seok Han, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 31, 2018
Recommandations de l'Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostateRicardo A Rendon, Ross J Mason, Karim Marzouk, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 1, 2019
Management algorithms for prostate-specific antigen progression in prostate cancer: Biochemical recurrence after definitive therapy and progression to non-metastatic castrate-resistant prostate cancerBrita Danielson, Fred Saad, Alan So, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancerKim N Chi, Martin E Gleave, Ladan Fazli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 26, 2018
The burden of symptomatic skeletal events in castrate-resistant prostate cancer patients with bone metastases at three Canadian uro-oncology centresFred Saad, Neil E Fleshner, Alan So, et al.
World Journal of Urology|March 1, 2018
The impact of time to metastasis on overall survival in patients with prostate cancerSebastian Frees, Shusuke Akamatsu, Samir Bidnur, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2017
CUA guideline on the management of cystic renal lesionsPatrick O Richard, Philippe D Violette, Michael A S Jewett, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 10, 2018
Natural history of prostatic lesions on serial multiparametric magnetic resonance imagingSamrad Ghavimi, Hamidreza Abdi, Jennifer Waterhouse, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 2, 2010
Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapyWassim Kassouf, Ashish M Kamat, Alexander Zlotta, et al.
Cancer Medicine|September 23, 2023
Economic evaluation of prostate cancer risk assessment methods: A cost-effectiveness analysis using population dataTima Mohammadi, Daphne P Guh, Alexander C T Tam, et al.
Oncotarget|June 2, 2018
The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinibSebastian Frees, Betty Zhou, Kyung Seok Han, et al.
Pageof 13